The Bladder Instillation Comparison Study (BIC)

S

Spectrum Health Hospitals

Status and phase

Completed
Phase 3

Conditions

Urinary Bladder Neoplasms

Treatments

Drug: Gemcitabine
Drug: Mitomycin C

Study type

Interventional

Funder types

Other

Identifiers

NCT02695771
2016-030

Details and patient eligibility

About

To compare the efficacy of Mitomycin C vs. Gemcitabine vs. no adjuvant treatment as a single intraoperative instillation in preventing recurrence of bladder cancer.

Full description

This study will compare standard of care treatment for patients with non-muscle invasive bladder cancer (NMIBC). Patients will be randomized to one of three arms, Mitomycin C, Gemcitabine or no additional treatment immediately following TURBT in the operating suite. All treatment, surgical procedures and follow up care will be conducted according to standard of care treatment.

Enrollment

101 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. sign an informed consent for the study
  2. be scheduled for a TURBT for suspected non-muscle invasive bladder tumor.

Exclusion criteria

  1. patients unable to consent for themselves
  2. individuals under 18 years old
  3. pregnant women
  4. prisoners
  5. patients with known allergy or intolerance to the mitomycin C or Gemcitabine
  6. any other sound medical, psychiatric and/or social reason as determined by the investigator.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

101 participants in 3 patient groups

Mitomycin C
Experimental group
Description:
Mitomycin C 40 mg in 40 mL of 0.9% sodium chloride intravesicular immediately following TURBT one time.
Treatment:
Drug: Mitomycin C
Gemcitabine
Active Comparator group
Description:
Gemcitabine 2 grams in 100 mL of 0.9% sodium chloride intravesicular immediately following TURBT one time.
Treatment:
Drug: Gemcitabine
No intervention
No Intervention group
Description:
Patients randomized to this arm will receive no intervention intravesicular immediately following TURBT one time.

Trial documents
1

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems